Literature DB >> 10860010

[Pharmacoepidemiology: definitions, problems, methodology].

B Bégaud1, J Dangoumau.   

Abstract

Pharmacoepidemiology aims to complete the evaluation of drugs made before approval, by providing reliable information concerning effectiveness, safety and utilization of medicines in realistic conditions. The goal may be only descriptive or aetiological. In the latter, the conclusions from observational studies can be jeopardized by systematic errors and cannot achieve the robustness of experimental designs. According to directionality, three main types of studies can be identified: cross-sectional, prospective and retrospective. Prospective and retrospective studies can be based on a single group (descriptive studies) or include a reference group (comparative or aetiologic studies). The interest of prospective studies is reduced when (1) the incidence of the considered event becomes low or (2) one intends to assess the effects of various causal factors. Retrospective studies are approaching their limits when (1) the prevalence of the exposure is low in the source-population or (2) several events or outcomes are concerned.

Mesh:

Year:  2000        PMID: 10860010

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  4 in total

1.  Hypnotics and infections: disproportionality analysis of the U.S. Food & Drug Administration adverse event reporting system database.

Authors:  Long Meng; Jing Huang; Qin He; Yibei Zhao; Wenlong Zhao; Juntao Tan; Shusen Sun; Junqing Yang
Journal:  J Clin Sleep Med       Date:  2022-09-01       Impact factor: 4.324

2.  Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.

Authors:  Wajd Alkabbani; Ryan Pelletier; Michael A Beazely; Youssef Labib; Breanna Quan; John-Michael Gamble
Journal:  Drug Saf       Date:  2022-03-05       Impact factor: 5.228

3.  Existence of Notoriety Bias in FDA Adverse Event Reporting System Database and Its Impact on Signal Strength.

Authors:  Reddy Neha; Viswam Subeesh; Elsa Beulah; Nair Gouri; Eswaran Maheswari
Journal:  Hosp Pharm       Date:  2019-10-18

4.  Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up.

Authors:  Fabiana Madotto; Sara Conti; Ippazio C Antonazzo; Domenico Ponticelli; Andrea Vitale; Giovanni Della Ragione; Maria L Romano; Mario Borrelli; Beniamino Schiavone; Riccardo Polosa; Pietro Ferrara; Lorenzo G Mantovani
Journal:  Intern Emerg Med       Date:  2021-10-12       Impact factor: 3.397

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.